Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 340
Filter
2.
Rev. méd. Urug ; 37(1): e702, mar. 2021. graf
Article in Spanish | LILACS, BNUY | ID: biblio-1180966

ABSTRACT

Resumen: Introducción: el hiperparatiroidismo primario por un adenoma gigante de paratiroides es infrecuente. Los adenomas de mayor tamaño reportados ocurrieron sobre paratiroides ectópicas (mediastinales). Comparte con el carcinoma su gran tamaño y elevadas cifras de calcemia y de hormona paratiroidea, hecho que dificulta el diagnóstico. Su tratamiento quirúrgico es la paratiroidectomía mediante una cervicotomía transversa centrada en la región infrahioidea. Objetivo: presentar un caso clínico de hiperparatiroidismo primario por un adenoma gigante de paratiroides tratado quirúrgicamente mediante un abordaje selectivo. Caso clínico: paciente de 53 años, sexo femenino, con antecedentes de litiasis ureteral, dolores óseos y tumoración infrahiodea de 4 cm de diámetro que imagenológicamente presentó las características de un adenoma paratiroideo inferior izquierdo. La valoración funcional confirmó hiperparatiroidismo. Con diagnóstico de hiperparatiroidismo primario por adenoma gigante se trató quirúrgicamente a través de una incisión pequeña y centrada en la tumoración, realizándose la paratiroidectomía inferior izquierda con la cual remitió la sintomatología y normalizó la funcionalidad paratiroidea. Discusión: el hiperparatiroidismo primario por adenoma gigante de paratiroides tiene indicación quirúrgica y es curativo. El caso presentado demuestra la factibilidad y seguridad de un abordaje selectivo a lo que suma una menor afectación cosmética, dejando indemne la logia tiroidea contralateral ante futuras cirugías sobre ésta.


Summary: Introduction: primary hyperparathyroidism caused by giant parathyroid adenoma is a rather unusual condition. Reported large adenomas occurred in ectopic parathyroid glands (mediastinal). Just like carcinomas, they are large, present high calcemia and parathyroid hormone values, what complicates diagnosis. Surgical treatment consists in parathyroidectomy by means of transversal cervicotomy around the infrahyoid region. Objective: the study presents the clinical case of primary hyperparathyroidism caused by giant parathyroid adenoma that was treated by selective surgery approach. Clinical case: 53 year-old female patient with a history of uretheral lithiasis, bone pain and 4-cm-diameter infrahyoid tumor. Imagenology studies revealed the characteristics of lower left parathyroid adenoma. Functional assessment confirmed hyperparathyroidism. Upon the diagnosis of primary hyperparathyroidism caused by giant parathyroid adenoma it was surgically addressed by means of a small cut around the tumour and performing a lower left parathyroidectomy, what resulted in the remission of symptoms and normalized parathyroid functionality. Discussion: primary hyperparathyroidism caused by giant parathyroid adenoma has an indication for surgery and is therapeutic. The case presented shows the feasibility and safety of a selective approach, as well as its smaller cosmetic harm, managing to keep the contralateral thyroid loggia intact, in view of future surgeries involving it.


Resumo: Introdução: o hiperparatireoidismo primário devido a adenoma de paratireoide gigante é raro. Os maiores adenomas relatados ocorreram em paratireoides ectópicas (mediastinais). Compartilha com o carcinoma seu grande tamanho e altos níveis de cálcio e hormônio da paratireoide, o que torna o diagnóstico difícil. Seu tratamento cirúrgico é a paratireoidectomia por meio de cervicotomia transversa com foco na região infra-hióidea. Objetivo: apresentar um caso clínico de hiperparatireoidismo primário por adenoma gigante da paratireoide tratado cirurgicamente por abordagem seletiva. Caso clínico: paciente do sexo feminino, 53 anos, com história de litíase ureteral, dor óssea e tumor infra-hióideo de 4 cm de diâmetro que apresentava características de imagem de adenoma de paratireoide inferior esquerdo. A avaliação funcional confirmou hiperparatireoidismo. Com diagnóstico de hiperparatireoidismo primário por adenoma gigante, foi tratada cirurgicamente por meio de pequena incisão focada no tumor, realizando paratireoidectomia inferior esquerda com remissão dos sintomas e normalização da funcionalidade da paratireoide. Discussão: o hiperparatireoidismo primário devido ao adenoma gigante da paratireoide tem indicação cirúrgica e é curativo. O caso apresentado demonstra a viabilidade e segurança de uma abordagem seletiva que apresenta um menor envolvimento estético, deixando o espaço contralateral da tireoide sem danos para futuras cirurgias.


Subject(s)
Parathyroid Neoplasms , Adenoma , Parathyroidectomy , Hyperparathyroidism, Primary/surgery
3.
Rev. colomb. cir ; 36(1): 110-119, 20210000. tab, fig
Article in Spanish | LILACS | ID: biblio-1150525

ABSTRACT

Durante las últimas décadas, la incidencia del hiperparatiroidismo primario ha venido en aumento, muy probablemente relacionado con la mayor accesibilidad a los estudios diagnósticos; sin embargo, la forma más común de presentación clínica del hiperparatiroidismo primario es asintomática, en más del 80 % de los pacientes. En la actualidad, es menos frecuente el diagnóstico por las complicaciones renales (urolitiasis) u óseas (osteítis fibrosa quística) asociadas. Un tumor benigno de la glándula paratiroides (adenoma único), es la principal causa de esta enfermedad. Por tanto, su tratamiento usualmente es quirúrgico. A pesar de ello, no es frecuente el manejo de esta patología por el cirujano general. En este artículo se revisan conceptos claves para el diagnóstico y manejo de esta enfermedad para el médico residente y especialista en Cirugía general


During the last decades, the incidence of primary hyperparathyroidism has been increasing, most probably related to the greater accessibility to diagnostic studies; however, the most common form of clinical presentation of primary hyperparathyroidism is asymptomatic in more than 80% of patients. Diagnosis is less frequent due to associated renal (urolithiasis) or bone (osteitis fibrosa cystica) complications. A benign tumor of the parathyroid gland (single adenoma) is the main cause of this disease. Therefore, its treatment is usually surgical. Despite this, the management of this pathology by the general surgeon is not frequent. This article reviews key concepts for the diagnosis and management of this disease for the resident physician and specialist in General Surgery


Subject(s)
Humans , Parathyroid Glands , Parathyroid Neoplasms , Parathyroidectomy , Hyperparathyroidism, Primary
5.
Rev. cuba. cir ; 59(3): e1008, jul.-set. 2020. tab
Article in Spanish | LILACS, CUMED | ID: biblio-1144435

ABSTRACT

RESUMEN Introducción: El tratamiento quirúrgico ha evolucionado desde la exploración abierta bilateral del cuello hasta la cirugía de invasión mínima. En este momento, la paratiroidectomía mínimamente invasiva en pacientes con hiperparatiroidismo primario es la técnica de elección. Objetivo: Describir los resultados del tratamiento quirúrgico del hiperparatiroidismo primario con el uso de la sonda gamma transoperatoria. Métodos: Se realizó un estudio descriptivo y longitudinal, de tipo serie de casos. La muestra estuvo constituida por 29 pacientes con tratamiento quirúrgico radioguiada para el hiperparatiroidismo primario en el Hospital Clínico Quirúrgico Hermanos Ameijeiras entre marzo de 2007 a diciembre de 2014. Resultados: De los 29 pacientes, 21 no presentaban enfermedad tiroidea asociada, tenían una mediana de edad de 52 años, con predominio femenino (80,9 por ciento), la enfermedad renal resultó ser el síntoma más frecuente (52,4 por ciento), el adenoma paratiroideo fue el diagnóstico anatomopatológico con mayor por ciento (85,7 por ciento). Presentaron complicaciones posoperatorias el 38,1 por ciento y la hipocalcemia transitoria estuvo en un 28,6 por ciento. La media de la estadía posoperatoria fue de 3,37 días y la curación de 90,5 por ciento. En los ocho pacientes con enfermedad tiroidea asociada tenían una mediana de edad de 58 años y predominio femenino (62,5 por ciento). Prevaleció el dolor articular y la fatiga (50 por ciento) como síntomas previos y como diagnóstico anatomopatológico el adenoma paratiroideo (62,5 por ciento). Las complicaciones presentes en un 37,5 por ciento y la más frecuente la hipocalcemia transitoria (25,0 por ciento). La curación estuvo en 62,5 por ciento y la media de la estadía posoperatoria en 2,47 días. Conclusiones: Los resultados alcanzados evidencian la utilidad de la cirugía radioguiada en el tratamiento del hiperparatiroidismo primario(AU)


ABSTRACT Introduction: Surgical treatment has evolved from bilateral open neck exploration to minimally invasive surgery. Currently, minimally invasive parathyroidectomy in patients with primary hyperparathyroidism is the technique of choice. Objective: To describe the outcomes of surgical treatment of primary hyperparathyroidism with the use of the intraoperative gamma probe. Methods: A descriptive and longitudinal study of case series was carried out. The sample consisted of 29 patients who received radioguided surgical treatment for primary hyperparathyroidism at Hermanos Ameijeiras Clinical-Surgical Hospital between March 2007 and December 2014. Results: Of the 29 patients, 21 did not present associated thyroid disease. Their median age was 52 years. They were predominantly female (80.9%). Kidney disease was the most frequent symptom (52.4 percent). Parathyroid adenoma was the anatomopathological diagnosis with the highest percentage value (85.7 percent). 38.1 percent presented postoperative complications and transient hypocalcemia accounted for 28.6 percent. The mean for postoperative stay was 3.37 days and for healing was 90.5 percent. In the eight patients with associated thyroid disease, the mean age was 58 years, and there was predominance of the female sex (62.5 percent). Joint pain and fatigue, accounting for 50 percent, prevailed as previous symptoms; while parathyroid adenoma, accounting for 62.5 percent, prevailed as anatomopathological diagnosis. Complications were present in 37.5 percent and the most frequent was transient hypocalcemia (25.0 percent). Healing accounted for 62.5 percent and the mean postoperative stay was 2.47 days. Conclusions: The results obtained show the usefulness of radioguided surgery in the treatment of primary hyperparathyroidism(AU)


Subject(s)
Humans , Female , Middle Aged , Parathyroidectomy/methods , Minimally Invasive Surgical Procedures/methods , Hyperparathyroidism, Primary/therapy , Epidemiology, Descriptive , Longitudinal Studies
6.
Prensa méd. argent ; 106(6): 366-370, 20200000. fig
Article in Spanish | LILACS, BINACIS | ID: biblio-1367080

ABSTRACT

Introducción: El síndrome de Sagliker es una enfermedad rara que requiere manejo de la vía aérea por personal experimentado, fue descrito en 2004 por Sagliker. Presentación del caso: Mujer de 30 años de edad, hipertensa con enfermedad renal crónica de 10 años de evolución, trasplante renal derecho con rechazo al año y manejada con hemodiálisis. Se le realizó paratiroidectomía bilateral, el manejo de la vía aérea fue con la paciente despierta y uso de fibroscopio. La evolución transoperatoria fue buena, se extubó sin incidentes y después de 3 días fue egresada a su domicilio. Conclusiones: El manejo de la vía aérea en pacientes con Síndrome de Sagliker requiere de experiencia ya que un manejo inadecuado compromete la vida de los pacientes.


Sagliker syndrome is a rare disease that requires airway management by experienced personnel, it was described in 2004 by Sagliker. Case presentation: 30-year-old woman, hypertensive with chronic kidney disease of 10 years of evolution, right kidney transplant with one-year rejection and managed with hemodialysis. A bilateral parotidectomy was performed, the airway was managed with the patient awake and using a fibroscope. The intraoperative evolution was good, she was extubated without incident and after 3 days she was discharged to her home. Conclusions: The management of the airway in patients with Sagliker Syndrome requires experience, since inadequate management compromises the lives of patients.


Subject(s)
Humans , Female , Adult , Parathyroidectomy , Renal Insufficiency, Chronic/surgery , Renal Insufficiency, Chronic/therapy , Airway Management/methods , Hyperparathyroidism, Secondary/complications
7.
Actual. osteol ; 16(1): 12-25, Ene - abr. 2020. ilus, graf, tab
Article in Spanish | LILACS | ID: biblio-1130045

ABSTRACT

La paratiroidectomía (PTX) es la terapia de elección en el hiperparatiroidismo secundario a enfermedad renal crónica (HPT-ERC) resistente al tratamiento médico. El objetivo del presente estudio fue evaluar el resultado de la PTX a largo plazo y sus factores predictores. Métodos: estudio unicéntrico retrospectivo observacional. Se incluyeron 92 pacientes con HPT-ERC en diálisis, en quienes se realizó la primera PTX en el Hospital Italiano de Buenos Aires entre 2006 y 2015 con seguimiento ≥ 6 meses. Se consideró persistencia del HPTERC con PTH > 300 pg/ml en el semestre posoperatorio, y recidiva con PTH > 500 pg/ml luego. Resultados: edad: 43,6±12,8 años, 50% mujeres, mediana 4,6 años de diálisis, PTH preoperatoria mediana 1639 pg/ml. A 39 se les realizó PTX subtotal (PTXS) y a 53 total con autoimplante (PTXT+AI). Se observó persistencia en 16 pacientes (17,4%). Presentaron recidiva 30 de 76 pacientes con adecuada respuesta inicial (39,5%; IC 95 28,5-50,5). La mediana de tiempo hasta la recidiva fue de 4,7 años (RIC 2,3-7,5). Los pacientes con recidiva presentaron mayor calcemia preoperatoria (mediana 9,9 vs. 9,3 mg/dl, p=0,035; OR ajustado 2,79) y menor elevación de fosfatasa alcalina en el posoperatorio (333 vs. 436 UI/l, p=0,031; OR ajustado 0,99). La recidiva se presentó más frecuentemente luego de la PTXT+AI (48,9%; OR ajustado 4,66), que en la PTXS (25,8%). Conclusiones: el tiempo en diálisis con inadecuado control metabólico constituye el principal factor para la recurrencia del HPT. Se postula que la mayor calcemia preoperatoria está relacionada con un HPT más severo y se asocia a recurrencia. Llamativamente, hallamos menores elevaciones de la fosfatasa alcalina durante el posoperatorio en pacientes con recurrencia. Hipotetizamos que esto pueda asociarse con menor mineralización en el posoperatorio e hiperfosfatemia sostenida, con consecuente estímulo paratiroideo. La menor recurrencia del HPT luego de la PTXS se vincula al sesgo generado en la selección del tipo de cirugía. (AU)


Parathyroidectomy is an effective therapy for refractory secondary hyperparathyroidism (sHPT). Continued dialysis represents risk for recurrent sHPT. The aim of this study was to estimate the proportion of recurrence and determine its predictors. Methods: We conducted a retrospective observational study of 92 adults in chronic dialysis, who underwent their first parathyroidectomy in this center between 2006 and 2015. We considered persistence of sHPT if PTH was > 300 pg/ml during the first postoperative semester, and recurrence if it was > 500 pg/ml afterwards. Results: Age 43.6+-12 y/o, 50% female, 4.6 years on dialysis, median preoperative PTH 1636 pg/ml (IQR 1226-2098). Subtotal parathyroidectomy (sPTX) was performed in 39, Total with autotransplantation (TA-PTX) in 53 patients. Persistence of sHPT occurred in 16 patients; relapse in 30 out of 76 with adequate initially response (39.5%; 95CI 28,5-50,5). Median time to recurrence: 4.7 y. Recurring patients had higher preoperative calcemia (9.9 vs 9.3 mg/dl; adj OR 2.79) and lower postoperative elevation of ALP (333 vs 436 UI/ml; adj OR 0.99). Recurrence presented more frequently in TA-PTX (48.9%; adj OR 4.66) than sPTX (25.8%). Conclusions: Time on dialysis with inadequate metabolic control remains the most important risk factor for sHPT recurrence. Higher preoperative levels of calcemia, related to sHPT severity, are associated with recurrence. Lower elevations of ALP during postoperative period in recurring patients are an interesting finding. We hypothesize that patients with less significant postoperative mineralization may have chronically higher levels of phosphatemia, stimulating parathyroid glands. Fewer recurrence in sPTX is associated to a bias in the procedure selection. (AU)


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Parathyroidectomy/statistics & numerical data , Hyperparathyroidism, Secondary/complications , Recurrence , Vitamin D/therapeutic use , Calcitriol/analogs & derivatives , Calcitriol/therapeutic use , Calcium/blood , Retrospective Studies , Renal Dialysis , Alkaline Phosphatase/blood , Renal Insufficiency, Chronic/etiology , Renal Insufficiency, Chronic/therapy , Hyperparathyroidism, Secondary/surgery , Hyperparathyroidism, Secondary/diagnosis , Hyperparathyroidism, Secondary/therapy
8.
Einstein (Säo Paulo) ; 18: eRC4819, 2020.
Article in English | LILACS | ID: biblio-1056060

ABSTRACT

ABSTRACT We describe a patient with tertiary hyperparathyroidism with history of three episodes of deep vein thrombosis and on rivaroxaban. The patient underwent a subtotal parathyroidectomy, developing cervical hematoma with airway compression. Therefore, emergency surgical decompression was necessary. Later, on the ninth postoperative day, the serum ionized calcium levels were low. Medical team knowledge about preexisting diseases and their implication in the coagulation state are essential conditions to reduce morbidity and mortality of surgeries. However, no reports were found in literature about the association of hypocalcemia with the use of the new class of anticoagulants, which act as factor X inhibitors (Stuart-Prower factor), predisposing to increased bleeding in the immediate postoperative period.


RESUMO Descrevemos um paciente com hiperparatireoidismo terciário com história de três episódios de trombose venosa profunda e em uso de rivaroxabana. O paciente foi submetido a uma paratireoidectomia subtotal, desenvolvendo hematoma cervical com compressão das vias aéreas. Foi necessária descompressão cirúrgica de emergência. No nono dia de pós-operatório, os níveis séricos de cálcio iônico estavam baixos. O conhecimento da equipe médica sobre doenças preexistentes e de sua implicação no estado de coagulação é condição indispensável para a redução da morbimortalidade do procedimento cirúrgico. No entanto, não há relatos na literatura associando hipocalcemia com o uso da nova classe de anticoagulantes que atuam como inibidores do fator X (fator de Stuart-Prower), predispondo ao aumento do sangramento no pós-operatório imediato.


Subject(s)
Humans , Male , Blood Coagulation Disorders/drug therapy , Factor Xa Inhibitors/adverse effects , Rivaroxaban/adverse effects , Hypocalcemia/chemically induced , Calcium/blood , Risk Factors , Parathyroidectomy/adverse effects , Parathyroidectomy/methods , Renal Insufficiency, Chronic/complications , Hyperparathyroidism/surgery , Hyperparathyroidism/etiology , Hypocalcemia/surgery , Middle Aged
9.
Rev. chil. endocrinol. diabetes ; 13(4): 154-158, 2020. ilus, tab
Article in Spanish | LILACS | ID: biblio-1123621

ABSTRACT

Introducción: El hiperparatiroidismo secundario (HPTS) es una complicación de la enfermedad renal crónica terminal (ERCT). A pesar de nuevas terapias médicas como calcimiméticos, en HPTS refractarios la paratiroidectomía (PTX) continúa siendo necesaria. Una complicación frecuente en estos pacientes posterior a la PTX es el síndrome de hueso hambriento (SHH), caracterizado por una profunda y prolongada hipocalcemia asociada a hipofosfatemia, secundaria a un excesivo aumento de su captación ósea. Una complicación menos descrita, pero con consecuencias graves e incluso fatales, es la hiperkalemia. El propósito de este trabajo consiste en enfatizar el riesgo de hiperkalemia por SHH a partir de un caso clínico, señalar los mecanismos fisiopatológicos, factores de riesgo y consideraciones terapéuticas. Caso clínico: Mujer de 35 años, con ERCT de causa desconocida, HPTS refractario con PTX total e implante de glándulas en antebrazo hace 9 años. Ingresa por recurrencia de HPTS. Cintigrama MIBI SPECT/CT® evidenció implante hiperfuncionante, indicándose PTX del injerto. Exámenes preoperatorios: calcemia 8.6 mg/dL, fosfatasas alcalinas 1115 UI/L (VN <100), PTH intacta (PTHi) 3509 pg/ml y kalemia 4.8 mEq/L. Biopsia: hiperplasia paratiroidea nodular. En postoperatorio inmediato presentó hiperkalemia de 7.1 mEq/L con cambios electrocardiográficos, requiriendo hemodiálisis de urgencia. Posteriormente desarrolló hipocalcemia, hipofosfatemia e hipomagnesemia, de difícil control. Discusión: El SHH post HPTS puede coexistir con hiperkalemia postoperatoria inmediata grave, incluso fatal si no se identifica y corrige a tiempo. El mecanismo fisiopatológico aún no está bien dilucidado. Varios factores pudieran intervenir, incluyendo aumento del metabolismo celular, traumatismo tisular, fármacos anestésicos, fluidos perioperatorios y flujo de iones transmembrana. El nivel de potasio previo a la cirugía, menor edad, género masculino, tiempo entre la última hemodiálisis y la cirugía, y duración de la PTX, son factores de riesgo para hiperkalemia postoperatoria. El conocimiento de esta grave complicación permitirá estar preparado para monitorizar y eventualmente tratar.


Introduction: Secondary Hyperparathyroidism (SHPT) is a complication of End-Stage Renal Disease (ESRD). Although new medical therapies (i.e.calcimimetics,) parathyroidectomy (PTX) continues to be necessary in refractory cases. A well-known complication after PTX is an entity called Hungry Bone Syndrome (HBS), characterized by deep and prolonged hypocalcemia associated with hypophosphatemia, secondary to an excessive increase in bone formation. A less reported complication, but with severe or even fatal consequences, is hyperkalemia. The purpose of this work consists of emphasizing the risk of hyperkalemia in HBS, reporting a clinical case that points out the physiopathological mechanisms, risk factors, and therapeutic considerations. Clinical case: 35-year-old woman with ESRD of unknown cause with refractory SHPT with total PTX and forearm gland grafts nine years ago. She presented SHPT recurrency. MIBI SPECT/CT® scan showed a hyperfunctioning implant, indicating graft PTX. Preoperative tests: calcemia 8.6 mg/dL, phosphatemia 7.3 mg/dL, alkaline phosphatases 1115 UI/L (VN<100), intact PTH (iPTH) 3509 pg/ml and kalemia 4.8 mEq/L. Biopsy: parathyroid nodular hyperplasia. In the immediate postoperative period, she presented hyperkalemia at 7.1 mEq/L with electrocardiographic changes, requiring emergency hemodialysis. Later she developed hypocalcemia, hypophosphatemia, and hypomagnesemia of difficult control. Discussion: HBS post PTX can coexist with severe immediate postoperative hyperkalemia, which can be even fatal if not detected and corrected. The physiopathological mechanism is still not entirely elucidated. Various factors could interfere, including an increase in cell metabolism, tissue traumatism, anesthetic drugs, intraoperative fluids, and transmembrane ion flow. Preoperative potassium levels, younger age, male gender, the time elapsed between last hemodialysis and surgery, and duration of PTX are risk factors for post-surgical hyperkalemia. Knowing this severe complication will allow the medical team to be prepared for monitoring and eventually treating it.


Subject(s)
Humans , Female , Adult , Bone Diseases, Metabolic/etiology , Parathyroidectomy/adverse effects , Hyperkalemia/etiology , Hyperparathyroidism, Secondary/surgery , Renal Insufficiency, Chronic/complications , Hyperparathyroidism, Secondary/complications
10.
Article in French | AIM, AIM | ID: biblio-1258761

ABSTRACT

Introduction: L'hyperparathyroïdie secondaire est une complication grave de l'insuffisance rénale chronique, ayant un impact négatif sur la morbi-mortalité. La parathyroïdectomie trouve toute son indication en cas d'échec du traitement médical. Le but de cette étude était de partager notre expérience dans la prise en charge de l'hyperparathyroïdie secondaire et de présenter les caractéristiques démographiques, biochimiques, cliniques et thérapeutiques des patients opérés dans notre service. Matériels et Méthodes : Etude d'une série de cas consécutifs opérés entre janvier 2002 et décembre 2013. Etaient inclus tous les patients ayant présenté une hyperparathyroïdie secondaire prouvée biologiquement et remplissant les critères d'opérabilité. Résultats : La série était composée de 69 patients (35 femmes, 34 hommes). La moyenne d'âge était de 37,7 ±13 ans. Le tableau clinique était dominé par les signes osseux et cutanés. En préopératoire, la valeur moyenne de la PTH était de 1727 ± 1380,10 pg/mL et celle de la calcémie de 2,39 ± 0,28 mmol/L. Sur le plan chirurgical, la parathyroïdectomie était subtotale chez 60 patients (87%) et totale chez 9 patients (13%) dont 7 avec auto transplantation et 2 sans autotransplantation. En post opératoire, la valeur de la PTH avait baissé significativement par rapport à la valeur préopératoire (p<0,01). Conclusion : Les résultats de cette étude suggèrent que la parathyroïdectomie entre les mains d'experts est un moyen efficace pour réduire la sécrétion de PTH avec une faible morbi-mortalité dans le cadre de l'hyperparathyroïdie secondaire réfractaire au traitement médical


Subject(s)
Algeria , Hyperparathyroidism, Secondary/complications , Hyperparathyroidism, Secondary/therapy , Parathyroidectomy , Renal Insufficiency, Chronic , Renal Insufficiency, Chronic/diagnosis
12.
Article in English | WPRIM | ID: wpr-785429

ABSTRACT

PURPOSE: Patients with secondary hyperparathyroidism are at high risk for developing postoperative hypocalcemia. However, there are limited data regarding predictors of postoperative hypocalcemia in renal failure patient with secondary hyperparathyroidism. This study aimed to determine the clinical presentations of renal hyperparathyroidism and the predictors of early postoperative hypocalcemia after total parathyroidectomy.METHODS: Data of patients with renal hyperparathyroidism who underwent total parathyroidectomy between January 2007 to December 2014 were reviewed retrospectively. Patients were divided into 2 cohort groups according to their serum calcium levels within 24 hours of parathyroidectomy: the hypocalcemia group (calcium levels of 2 mmol/L or less), and the normocalcemia group (calcium levels more than 2 mmol/L). With the use of multivariable logistic regression analyses, the predictors of early postoperative hypocalcemia after total parathyroidectomy in patients with renal hyperparathyroidism were investigated.RESULTS: Among 68 patients, 56 patients (82.4%) were symptomatic preoperatively. Fifty patients (73.5%) presented with bone pain and 14 patients (20.6%) had muscle weakness. Early postoperative hypocalcemia occurred in 25 patients (36.8%). Preoperative alkaline phosphatase level was the predictor of early postoperative hypocalcemia (adjusted odds ratio, 1.004; 95% confidence interval, 1.001–1.006; P = 0.002).CONCLUSION: Results from our study show that most of the patients with renal hyperparathyroidism were symptomatic preoperatively and the most common clinical presentations were bone pain and muscle weakness. The significant predictor of early postoperative hypocalcemia after total parathyroidectomy was the preoperative alkaline phosphatase levels.


Subject(s)
Alkaline Phosphatase , Calcium , Cohort Studies , Humans , Hyperparathyroidism , Hyperparathyroidism, Secondary , Hypocalcemia , Logistic Models , Muscle Weakness , Odds Ratio , Parathyroid Hormone , Parathyroidectomy , Renal Insufficiency , Retrospective Studies
14.
Rev. méd. Chile ; 147(8): 1078-1081, ago. 2019. graf
Article in Spanish | LILACS | ID: biblio-1058646

ABSTRACT

Acute pancreatitis during pregnancy is uncommon and usually associated with gallstones. However other etiologies must be considered. We report a 24 years old woman with a 32 weeks pregnancy consulting for abdominal pain, nausea and vomiting. She had elevated lipase and amylase levels, a corrected serum calcium of 13.1 mg/dl and a serum phosphate of 1.6 mg/dl. A magnetic resonance colangiopancreatography showed an enlarged pancreas with inflammatory changes and a normal Wirsung duct. A parathyroid nodule was found on cervical ultrasonography. The patient was treated initially with cinacalcet with partial response. A parathyroidectomy was performed at 39 weeks of pregnancy with a good maternal and fetal evolution.


Subject(s)
Humans , Female , Pregnancy , Young Adult , Pancreatitis/etiology , Pregnancy Complications/etiology , Hypercalcemia/complications , Pancreatitis/surgery , Pancreatitis/diagnostic imaging , Parathyroid Neoplasms/diagnostic imaging , Pregnancy Complications/surgery , Adenoma/diagnostic imaging , Abdominal Pain/etiology , Parathyroidectomy/methods , Treatment Outcome , Cholangiopancreatography, Magnetic Resonance/methods
15.
Arch. endocrinol. metab. (Online) ; 63(4): 394-401, July-Aug. 2019. tab, graf
Article in English | LILACS | ID: biblio-1019358

ABSTRACT

ABSTRACT Objective To measure type 1 serum amino-terminal propeptide procollagen (P1NP) and type 1 cross-linked C-terminal telopeptide collagen (CTX) before parathyroidectomy (PTX) in PHPT patients, correlating these measurements with bone mineral density (BMD) changes. Subjects and methods 31 primary hyperparathyroidism (HPTP) were followed from diagnosis up to 12-18 months after surgery. Serum levels of calcium, parathyroid hormone (PTH) vitamin D, CTX, P1NP, and BMD were measured before and 1 year after surgery. Results One year after PTX, the mean BMD increased by 8.6%, 5.5%, 5.5%, and 2.2% in the lumbar spine, femoral neck (FN), total hip (TH), and distal third of the nondominant radius (R33%), respectively. There was a significant correlation between BMD change 1 year after the PTX and CTX (L1-L4: r = 0.614, p < 0.0003; FN: r = 0.497, p < 0.0051; TH: r = 0.595, p < 0.0005; R33%: r = 0.364, p < 0.043) and P1NP (L1-L4: r = 0,687, p < 0,0001; FN: r = 0,533, p < 0,0024; TH: r = 0,642, p < 0,0001; R33%: r = 0,467, p < 0,0079) preoperative levels. The increase in 25(OH)D levels has no correlation with BMD increase (r = -0.135; p = 0.4816). On linear regression, a minimum preoperative CTX value of 0.331 ng/mL or P1NP of 37.9 ng/mL was associated with a minimum 4% increase in L1-L4 BMD. In TH, minimum preoperative values of 0.684 ng/mL for CTX and 76.0 ng/mL for P1NP were associated with a ≥ 4% increase in BMD. Conclusion PHPT patients presented a significant correlation between preoperative levels of turnover markers and BMD improvement 1 year after PTX.


Subject(s)
Humans , Male , Female , Middle Aged , Aged , Peptide Fragments/metabolism , Peptides/metabolism , Bone Density , Parathyroidectomy/rehabilitation , Procollagen/metabolism , Collagen Type I/metabolism , Hyperparathyroidism, Primary/metabolism , Parathyroid Hormone/blood , Peptide Fragments/blood , Postoperative Period , Vitamin D/blood , Biomarkers/blood , Calcium/blood , Predictive Value of Tests , Procollagen/blood , Hyperparathyroidism, Primary/surgery
16.
J. bras. nefrol ; 41(2): 304-305, Apr.-June 2019. graf
Article in English | LILACS | ID: biblio-1012531

ABSTRACT

Abstract Mineral bone disorder is a common feature of chronic kidney disease. Lion face syndrome is rare complication of severe hyperparathyroidism in end-stage renal disease patients, which has been less commonly reported due to dialysis and medical treatment advances in the last decade. The early recognition of the characteristic facial deformity is crucial to prompt management and prevent severe disfigurement. The authors present a rare case of severe hyperparathyroidism presenting with lion face syndrome and bone fractures.


Resumo O distúrbio mineral e ósseo é uma característica comum da doença renal crônica. A síndrome da face leonina é uma complicação rara do hiperparatireoidismo grave em pacientes com doença renal terminal, que tem sido menos relatada devido aos avanços na diálise e tratamento médico na última década. O reconhecimento precoce da deformidade facial característica é crucial para estimular o tratamento precoce e prevenir a desfiguração severa. Os autores apresentam um caso raro de hiperparatireoidismo grave, apresentando síndrome da face leonina e fraturas ósseas.


Subject(s)
Humans , Female , Adult , Chronic Kidney Disease-Mineral and Bone Disorder/complications , Hyperostosis Frontalis Interna/diagnosis , Hyperostosis Frontalis Interna/etiology , Kidney Failure, Chronic/complications , Postoperative Complications/drug therapy , Bone Density , Hyperostosis Frontalis Interna/surgery , Ergocalciferols/therapeutic use , Calcium/therapeutic use , Parathyroidectomy/adverse effects , Renal Dialysis , Treatment Outcome , Teriparatide/therapeutic use , Fractures, Bone/diagnosis , Bone Density Conservation Agents/therapeutic use , Hypocalcemia/etiology , Hypocalcemia/drug therapy
17.
Arch. endocrinol. metab. (Online) ; 63(2): 182-185, Mar.-Apr. 2019. tab
Article in English | LILACS | ID: biblio-1038494

ABSTRACT

ABSTRACT Objective: To define serum parathyroid hormone (PTH) reference values in carefully selected subjects following the recommended pre-analytical guidelines. Subjects and methods: First, 676 adults who would be submitted to thyroidectomy were evaluated. Patients using interfering medications or with malabsorption syndrome, hypomagnesemia, hyper- or hypophosphatemia, hypo- or hypercalcemia, 25-hydroxyvitamin D < 30 ng/dL, estimated glomerular filtration rate < 60 mL/min/1.73 m2, urinary calcium/creatinine ratio ≥ 0.25, thyroid dysfunction, parathyroid adenoma detected during surgery were excluded. The sample consisted of 312 subjects. Results: The median, minimum, maximum, and 2.5th and 97.5th percentiles of the PTH values obtained were 30, 7.2, 78, 10.1, and 52 pg/mL, respectively. Thus, the reference range was 10 to 52 pg/mL. PTH > 65 pg/mL, the upper limit of normal according to the manufacturer of the kit, was observed in only one subject (0.3%). Considering the upper limit proposed by the kit's manufacturer, 1/6 hypercalcemic patients and 4/8 normocalcemic patients with PHPT had normal PTH. Using the upper limit established in this study, only one normocalcemic patient had normal PTH. Thus, the sensitivity of PTH in detecting asymptomatic primary hyperparathyroidism (PHPT) using the values recommended by the kit and established in this study was 64% and 93%, respectively (50% versus 87.5% for normocalcemic PHPT). Conclusion: The upper reference limit of PTH obtained for a rigorously selected sample was 20% lower than that provided by the assay, which increased its sensitivity in detecting PHPT.


Subject(s)
Humans , Male , Female , Adolescent , Adult , Middle Aged , Aged , Young Adult , Parathyroid Hormone/blood , Thyroid Nodule/blood , Hyperparathyroidism/diagnosis , Parathyroid Hormone/standards , Reference Values , Thyroidectomy , Vitamin D/analogs & derivatives , Vitamin D/blood , Brazil , Calcium/urine , Prospective Studies , Parathyroidectomy , Sensitivity and Specificity , Premenopause/blood , Postmenopause/blood , Hyperparathyroidism/blood
18.
Article in Korean | WPRIM | ID: wpr-764087

ABSTRACT

Secondary hyperparathyroidism (HPT) usually result from parathyroid gland hyperplasia that produces excess parathyroid hormone (PTH). Decreased renal function leads to elevate serum phosphate levels and reduce vitamin D production, which results in hypocalcemia. Skeletal resistance to PTH results in persistently and frequently extremely elevated PTH levels and renal osteopathy. Treatment of choice for secondary HPT is medical management including calcitriol and vitamin D. However, for some cases in calciphylaxis and the failure including PTH >800 pg/mL or osteoporosis under maximal medical management surgical intervention could be an alternative option. We described a case of 47-year-old woman with surgical intervention for secondary hyperparathyroidism.


Subject(s)
Autografts , Calciphylaxis , Calcitriol , Female , Humans , Hyperparathyroidism, Secondary , Hyperplasia , Hypocalcemia , Middle Aged , Osteoporosis , Parathyroid Glands , Parathyroid Hormone , Parathyroidectomy , Transplantation, Autologous , Vitamin D
19.
Article in English | WPRIM | ID: wpr-762612

ABSTRACT

Primary hyperparathyroidism (PHPT) and familial hypocalciuric hypercalcemia (FHH) have significantly different treatment approaches, so physicians must be careful to differentiate these 2 diseases. Herein, we report a 14-year-old female who presented with symptomatic hypercalcemia (12 mg/dL; reference range, 9.2–10.7 mg/dL), elevated intact parathyroid hormone (iPTH) (236 pg/mL; reference range, 9–69 pg/mL), and vitamin D deficiency (6 ng/mL; reference range, ≥ 20 ng/mL). On numerous occasions, her 24-hour urine calcium was more than 4 mg/kg/day, consistent with PHPT, but her fractional excretion of calcium on 24-hour urine collection was consistently below 1%, in line with FHH. ⁹⁹mTc-Sestamibi scan failed to detect any abnormalities. However, a 4-dimensional computed tomography scan of the neck revealed a right superior parathyroid adenoma which was excised with a focused parathyroidectomy. Although the patient’s calcium and iPTH levels normalized, her nonspecific symptoms persisted. This case illustrates both the challenges of differentiating PHPT from FHH and the limitations of a first-line imaging tool in identifying a parathyroid adenoma.


Subject(s)
Adolescent , Calcium , Female , Humans , Hypercalcemia , Hyperparathyroidism, Primary , Neck , Parathyroid Hormone , Parathyroid Neoplasms , Parathyroidectomy , Reference Values , Urine Specimen Collection , Vitamin D Deficiency
20.
Article in Korean | WPRIM | ID: wpr-787535

ABSTRACT

Parathyroid adenoma can cause extracapsular bleeding. In 1934, Capps first reported a case of massive hemorrhage secondary to rupture of a parathyroid adenoma. Recently, we experienced a 73-year-old female presented with pharyngeal discomfort and extensive ecchymosis over the neck without history of trauma. Endoscopic investigation revealed submucosal hemorrhage in the posterior wall of the hypopharynx. CT scan and ultrasonography demonstrated the presence of a mass below the left thyroid lobe. Serum calcium level was normal and PTH level was elevated. We underwent left thyroidectomy and parathyroidectomy 2 weeks later from first visit. During the operation, hypopharyngeal mucosa was teared and it was treated with pharyngostoma formation and L-tube feeding. We report a rare case of normocalcemic parathyroid adenoma with spontaneous hemorrhage and propose the proper management period with a literature review


Subject(s)
Aged , Calcium , Ecchymosis , Female , Hematoma , Hemorrhage , Humans , Hypopharynx , Mucous Membrane , Neck , Parathyroid Neoplasms , Parathyroidectomy , Rupture , Tears , Thyroid Gland , Thyroidectomy , Tomography, X-Ray Computed , Ultrasonography
SELECTION OF CITATIONS
SEARCH DETAIL